ML-9 NEW
| Price | $31 | $58 | $86 |
| Package | 10mg | 25mg | 50mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-27 |
Product Details
| Product Name: ML-9 | CAS No.: 105637-50-1 |
| Purity: 99.69% | Supply Ability: 10g |
| Release date: 2026/07/27 |
Product Introduction
Bioactivity
| Name | ML-9 |
| Description | ML-9 suppresses MLCK, PKA, and PKC activity with Ki values of 4, 32, and 54 μM, respectively. ML-9 is a selective and effective inhibitor of Akt kinase, inhibits myosin light-chain kinase (MLCK), and stromal interaction molecule 1 (STIM1) activity. ML-9 causes autophagy by stimulating autophagosome formation and inhibiting their degradation. |
| In vitro | ML9 (50?μM; 1-4?hours) obviously enhances cleaved caspase-3 levels, reduced STIM1 protein levels by about 42%. ML9 (0-100?μM; 0-24?hours) has no reduction in cardiomyocyte viability, 50-100?μM obviously causes cell death [2]. |
| Storage | Keep away from moisture, Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.54 mM), Sonication is recommended. DMSO : 245 mg/mL (678.13 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (27.68 mM), Solution. |
| Keywords | viability | STIM1 | Myosin | MLCK | ML-9 | ML9 | ML 9 | Inhibitor | inhibit | caspase | cardiomyocyte | CalciumChannel | Calcium Channel | AKT |
| Inhibitors Related | Quadrol | Aceglutamide | 2,4,6-Tri-tert-butylphenol | Carbamazepine | Chlorocresol | Hyaluronic acid | L-Ascorbic acid | Ethyl linoleate | L-Ascorbic acid sodium salt | 2,3-Butanediol | Magnesium Chloride Hexahydrate | Magnesium sulfate |
| Related Compound Libraries | Anti-Lung Cancer Compound Library | Glycolysis Compound Library | Pain-Related Compound Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Kinase Inhibitor Library | Inhibitor Library | Neuroprotective Compound Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Ion Channel Targeted Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $10.00 |
VIP2Y
|
Ningbo Qingteng Plastic Cost.,Ltd.
|
2026-08-07 | |
| $2500.00 |
VIP3Y
|
TargetMol Chemicals Inc.
|
2026-07-27 | |
| $72.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-07-27 | |
| $1.00 |
VIP7Y
|
Career Henan Chemical Co
|
2020-01-05 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY